🇺🇸 Denosumab treatment in osteoporotic patients in United States

Denosumab treatment in osteoporotic patients (Denosumab treatment in osteoporotic patients) regulatory status in United States.

Marketing authorisation

FDA

• Status: approved

Frequently asked questions

Is Denosumab treatment in osteoporotic patients approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Denosumab treatment in osteoporotic patients in United States?

Shinshu University is the originator. The local marketing authorisation holder may differ — check the official source linked above.